1 week Ago By ABMN Staff
Norges Bank purchased a new position in Teladoc Health, Inc. ( NYSE:TDOC – Free Report ) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 178,000 shares of the health services provider’s stock, valued at approximately $1,618,000.
Norges Bank owned approximately 0.10% of Teladoc Health at the end of the most recent reporting period. A number of other institutional investors have also recently made changes to their positions in the stock.
Geode Capital Management LLC raised its holdings in shares of Teladoc Health by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after buying an additional 56,864 shares in the last quarter.
Versant Capital Management Inc grew its position in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares during the last quarter.
Robeco Institutional Asset Management B.V. raised its stake in shares of Teladoc Health by 21.
8% during the fourth quarter. Robeco Institutional Asset Management B.V.
now owns 700,166 shares of the health services provider’s stock worth $6,365,000 after acquiring an additional 125,111 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Teladoc Health by 20,936.8% in the 4th quarter.
Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after acquiring an additional 424,180 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Teladoc Health by 18.
7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock valued at $22,213,000 after purchasing an additional 384,528 shares in the last quarter.
Institutional investors own 76.82% of the company’s stock. Teladoc Health Price Performance TDOC stock opened at $7.
26 on Friday. The firm has a 50-day moving average of $9.73 and a 200 day moving average of $9.
69. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.
73 and a quick ratio of 1.69. The company has a market cap of $1.
26 billion, a P/E ratio of -1.26 and a beta of 1.73.
Teladoc Health, Inc. has a 1 year low of $6.61 and a 1 year high of $15.
21. Insider Transactions at Teladoc Health In other news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction that occurred on Thursday, March 20th.
The stock was sold at an average price of $8.42, for a total value of $92,712.62.
Following the sale, the insider now directly owns 64,308 shares of the company’s stock, valued at $541,473.36. The trade was a 14.
62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website . Insiders own 0.
95% of the company’s stock. Wall Street Analysts Forecast Growth Several analysts have weighed in on the stock. Bank of America lowered their price target on shares of Teladoc Health from $9.
50 to $8.00 and set a “neutral” rating for the company in a research note on Friday. Piper Sandler lowered their target price on Teladoc Health from $13.
00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Oppenheimer reduced their price target on Teladoc Health from $14.
00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group decreased their price target on Teladoc Health from $16.
00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Finally, Royal Bank of Canada increased their price objective on Teladoc Health from $11.
00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock.
According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $10.94.
Check Out Our Latest Stock Report on Teladoc Health About Teladoc Health ( Free Report ) Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter ..
